RNA-seq analysis of human pancreas cell line SU8686 treated with DOT1L inhibitor (SGC0946) or DMSO
收藏NIAID Data Ecosystem2026-04-29 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP226165
下载链接
链接失效反馈官方服务：
资源简介：
To understand the pathway alteration associated with DOT1L inhibition, we performed RNA-seq analysis of DOT1L inhibitor treated human pancreas cell line SU8686. We reported the changed pathways. Overall design: The SU8686 cells were treated with 20 µM SGC0946 or DMSO for 72 hr (triplicate)
创建时间：
2021-09-23
